Correction: Maurer et al. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. J. Fungi 2022, 8, 1265

Key Points

• The research aims to investigate how gut microbial changes affect patients with COVID-19 and pulmonary aspergillosis.
• Evaluated gut microbial composition in critically ill patients
• Compared patients with and without pulmonary aspergillosis
• Analyzed immune response markers in relation to gut microbiota
• Observed significant microbial disruption in patients with pulmonary aspergillosis
• Identified specific gut bacteria associated with immune responses
• Highlighted potential correlations between gut health and severe COVID-19 outcomes